View Older Stories View More Recent Stories
-
AveXis (AVXS): Raising PT on Strong P1 Data - BMO
-
Fate Therapeutics (FATE) PT Raised to $7 at BMO Capital
-
AK Steel Announces Pricing of $400,000,000 of Senior Notes due 2027
-
Bank of Montreal Announces Quarterly Coupon Amount for the BMO Elkhorn DWA MLP Selectâ„¢ Index ETN
-
Canada Goose (GOOS) IPO Opens up 41%
-
Canada Goose (GOOS) IPO Indicated Sharply Higher in Toronto; Could More Than Double on Open
-
AK Steel Announces Offering of $400,000,000 of Senior Notes and Cash Tender Offer for its 7.625% Senior Notes Due 2020
-
Canada Goose (GOOS) IPO Prices at C$17, Above Expected Range
-
Canada Goose Announces Pricing of Initial Public Offering
-
UPDATE: BMO Capital Starts REV Group (REVG) at Outperform
-
Party City (PRTY) PT Lowered to $16 at BMO Capital; Reiterates Market Perform
-
Strayer Education (STRA) PT Raised to $88 at BMO Capital; 'Our Favorite Post Secondary Name'
-
Arista Networks (ANET) PT Raised to $145 at BMO Capital; Router Opportunity can be '~$350M Revenue by 2020'
-
UPDATE: BMO Capital Upgrades Healthcare Realty Trust (HR) to Outperform
-
U.S. producer prices rise broadly, point to firming inflation
-
Amphastar Pharmaceuticals (AMPH) PT Lowered to $16 at BMO Capital Following 4Q EPS Miss
-
BMO Capital Downgrades Abbott Labs (ABT) to Market Perform
-
Valeant Pharmaceuticals (VRX) PT Lowered to $15 at BMO Capital
-
BMO Financial Group Proxy Circular Now Available
-
BMO CEO Bill Downe Signatory to Catalyst CEO Champions for Change
-
CMP 2017 Resource Limited Partnership Raises $5.29 Million on Second and Final Closing
-
BMO Capital Reiterates Outperform Rating and $15 PT on Neos Therapeutics (NEOS); 'Steady Growth in Adzenys XR-ODT'
-
Tetraphase Pharma (TTPH) Climbs 17% Following BMO Capital Upgrade to Outperform
-
New Gold Closes US$173 Million Bought Deal Financing
-
BMO Capital Downgrades Winnebago Industries (WGO) to Outperform
-
BMO Capital Reiterates Outperform Rating and $295 PT on Ulta Salon (ULTA) Following 4Q EPS Beat; ' Many Positives'
-
BMO Capital Upgrades Tetraphase Pharmaceuticals (TTPH) to Outperform
-
Monmouth Real Estate Investment Corporation Announces Closing of Preferred Stock Offering
-
AIG (AIG) CEO Resignation 'A Positive for the Stock'; Reiterate Outperform and $70 PT - BMO Capital
-
Mitel Announces Closing of New Credit Facility
-
e.l.f. Beauty (ELF) PT Raised to $38 at BMO Capital on Strong 4Q EPS Beat; 'Higher Conviction in Upside'
-
BMO Capital Upgrades Greif Inc. (GEF) to Market Perform
-
BMO Capital Reiterates Outperform Rating and $30 PT on Ciena (CIEN); 'Many Demand Drivers, Buyers on Weakness'
-
Casey's General Stores (CASY) PT Lowered to $108 at BMO Capital; 'Lowering Merchandise Sales and Margin Forecasts'
-
Gibsons Commences Cash Tender Offers for Outstanding Canadian Dollar Notes due 2020 and U.S. Dollar Notes due 2021
-
Rigel Pharma (RIGL) Reiterates Outperform Rating and $4 PT on Rigel Pharma (RIGL); 'Focused on Fostamatinib's Pending NDA Submission'
-
JBT Corp. (JBT) Prices 2M Share Offering at $85
-
John Bean Technologies Corporation Prices Public Offering of Common Stock
-
Arch Coal, Inc. Announces Successful Closing of $300 Million Senior Secured Term Loan Facility
-
BMO Financial Group rings the NYSE Opening Bell to mark its 200 years in business
-
BMO Capital Downgrades Nimble Storage (NMBL) to Market Perform Amid Takeover
-
NVIDIA (NVDA): Sticking with Underperform - BMO
-
General Motors (GM): Good Value Creation Focus But Not a Meaningful Transaction - BMO
-
BMO Capital Maintains Outperform Rating and $45 PT on Hain Celestial (HAIN); 'Risk-Reward Looks Favorable'
-
BMO Capital Maintains Market Perform Rating and $78 PT on Vertex Pharma (VRTX) Following Concert CTP-656 Acquisition
-
Ionis Pharmaceuticals (IONS) PT Lowered to $59 at BMO Capital on Volanesorsen Data; 'Compliance Rate to 75% from 85%'
-
Ra Pharma (RARX) PT Raised to $31 at BMO Capital on Positive RA101495 Expectations
-
Monmouth Real Estate Investment Corporation Announces Pricing Of Preferred Stock Offering
-
JBT Corp. (JBT) to Offer 2M Common Shares
-
John Bean Technologies Corporation Announces Public Offering of 2,000,000 Shares of Common Stock


